Skip to content

Debt Repayments at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2B
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.41B+68.5%
Danaher logo
DanaherDHR
$1.43B
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$476K+1.3%
TEC
Bio-TechneTECH
$60M+650%
Revvity logo
RevvityRVTY
$0+100%

Other financials

Income statement

See full
Revenue$44.1M+6.5%
Gross profit$21.3M+5.4%
Operating income-$18.5M-23.3%
Net income-$18.9M-65.5%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$31.8M-66.6%
Total debt$16.8M+40.9%
Total equity$327.6M-13.7%
Total assets$449.1M-6.9%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+155%
Free cash flow-$4.9M-403%

Valuation

See full
Market cap$577.27M+54.5%
Enterprise value$562.23M+93.7%
P/S2.8×+0.9×

Profitability

See full
Gross margin51.7%-3.2pp
Operating margin-21.5%
Net margin-36.2%
FCF margin-6.2%-15.1pp

Returns & leverage

See full
Return on equity-20.9%
Debt / equity0.1×0.0×
Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfDebt.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s debt repayments?
Cytek Biosciences, Inc. (CTKB) reported debt repayments of $869K in Q1 2026.
How has Cytek Biosciences, Inc.'s debt repayments changed year-over-year?
Cytek Biosciences, Inc.'s debt repayments decreased by 42.8% year-over-year, from $1.52M to $869K.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.